Matricelf Ltd (MTLF) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Matricelf Ltd (MTLF) has a cash flow conversion efficiency ratio of -997.589x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-8.28 Million ≈ $-22.18K USD) by net assets (ILA8.29K ≈ $22.24 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see MTLF stock market capitalisation for the company's overall valuation and market capitalisation.
Matricelf Ltd - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Matricelf Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Matricelf Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Matricelf Ltd ranked by their cash flow conversion efficiency. See MTLF debt coverage from operations to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
TMK Energy Ltd
AU:TMK
|
-0.030x |
|
Garden Stage Limited Ordinary Shares
NASDAQ:GSIW
|
-0.034x |
|
Shin Poong Pap
KO:002870
|
0.008x |
|
Retractable Technologies Inc
NYSE MKT:RVP
|
-0.008x |
|
SCI Electric Public Company Limited
BK:SCI
|
0.031x |
|
Prefab Bucures
RO:PREH
|
0.052x |
|
Australian Rare EARTHS Ltd
AU:AR3
|
-0.007x |
|
NOMADAR Corp. Class A Common Stock
NASDAQ:NOMA
|
-0.042x |
Annual Cash Flow Conversion Efficiency for Matricelf Ltd (2019–2024)
The table below shows the annual cash flow conversion efficiency of Matricelf Ltd from 2019 to 2024. View latest Matricelf Ltd stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ILA15.17 Million ≈ $40.66K |
ILA-11.75K ≈ $-31.51 |
-0.001x | -98.09% |
| 2023-12-31 | ILA26.80 Million ≈ $71.86K |
ILA-10.49K ≈ $-28.12 |
0.000x | +99.83% |
| 2022-12-31 | ILA35.79 Million ≈ $95.96K |
ILA-8.30 Million ≈ $-22.25K |
-0.232x | +8.20% |
| 2021-12-31 | ILA26.23 Million ≈ $70.32K |
ILA-6.62 Million ≈ $-17.76K |
-0.253x | +79.57% |
| 2020-12-31 | ILA2.80 Million ≈ $7.50K |
ILA-3.46 Million ≈ $-9.27K |
-1.236x | -1354.61% |
| 2019-12-31 | ILA3.62 Million ≈ $9.71K |
ILA-307.80K ≈ $-825.19 |
-0.085x | -- |
About Matricelf Ltd
Matricelf Ltd, a biotechnology company, develops a platform for autologous tissue engineering for various medical conditions. The company's regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson's disease, and myocardial infarction, as well as for 3D bioprinting. Matricelf Ltd was incorporated in 20… Read more